These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12511533)

  • 21. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
    J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study.
    Verdecchia P; Dovellini EV; Gorini M; Gozzelino G; Lucci D; Milletich A; Maggioni AP
    Ital Heart J; 2000 Mar; 1(3):207-15. PubMed ID: 10806988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Cicala S; de Simone G; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2008 Apr; 26(4):806-12. PubMed ID: 18327092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
    Wachtell K; Palmieri V; Olsen MH; Bella JN; Aalto T; Dahlöf B; Gerdts E; Wright JT; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H; Devereux RB
    Am Heart J; 2002 Feb; 143(2):319-26. PubMed ID: 11835038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. The LIFE Study.
    Cicala S; Devereux RB; de Simone G; Wachtell K; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Okin PM
    Am J Hypertens; 2007 Jul; 20(7):771-6. PubMed ID: 17586412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.
    Søraas CL; Wachtell K; Okin PM; Dahlöf B; Devereux RB; Tønnessen T; Kjeldsen SE; Olsen MH
    Blood Press; 2010 Jun; 19(3):145-51. PubMed ID: 20429689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of electrocardiographic findings for diagnosis of left ventricular hypertrophy in patients with primary aldosteronism.
    Kurisu S; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Kihara Y
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):131-6. PubMed ID: 23535447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study.
    Stokke IM; Li ZB; Cicala S; Okin PM; Kjeldsen SE; Devereux RB; Wachtell K
    Blood Press; 2019 Apr; 28(2):84-92. PubMed ID: 30698038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients.
    Ishikawa J; Yamanaka Y; Toba A; Watanabe S; Harada K
    Int Heart J; 2017 Dec; 58(6):933-938. PubMed ID: 29162779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Am Coll Cardiol; 1995 Feb; 25(2):417-23. PubMed ID: 7829796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ; Dubey E; Brody A; Welch R; Zalenski R; Flack JM; Ference B; Levy PD
    Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM; Hille DA; Kjeldsen SE; Devereux RB
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
    J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data).
    Greve AM; Gerdts E; Boman K; Gohlke-Baerwolf C; Rossebø AB; Hammer-Hansen S; Køber L; Willenheimer R; Wachtell K
    Am J Cardiol; 2011 Aug; 108(4):541-7. PubMed ID: 21624542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease.
    Cordeiro AC; Lindholm B; Sousa MG; Picotti JC; Nunes GJ; Santana MR; Grimaldi W; Amparo FC; Amodeo C; Carrero JJ
    J Hypertens; 2014 Feb; 32(2):439-45. PubMed ID: 24317549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.